OLUTASIDENIB | OLUTASIDENIB | ANTINEOPLASTIC ISOCITRATE DEHYDROGENASE-1 (IDH1) INHIBITOR TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) WITH A SUSCEPTIBLE IDH1 MUTATION | ORAL | Cmax 10.1 MICROMOLAR Tmax 4 HOUR VD 319 LITER PPB 93 PERCENT Cl 4 LITER / HOUR HT 67 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | ISOCITRATE DEHYDROGENASE-1 (IDH1) PDB 6U4J (CRYSTAL STRUCTURE OF IDH1 R132H MUTANT IN COMPLEX WITH FT-2102) LIGAND CODE = PWV (link to the list of PDB complexes) Download experimental 3D coordinates of PWV with added hydrogens | Isocitrate dehydrogenase NADP cytoplasmic IDH1 UNIPROT O75874 IDH1 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |